View in EDS HTML Full Text PDF Full Text

Identification of a Novel SSTR3 Full Agonist for the Treatment of Nonfunctioning Pituitary Adenomas.

Saved in:
Bibliographic Details
Title: Identification of a Novel SSTR3 Full Agonist for the Treatment of Nonfunctioning Pituitary Adenomas.
Authors: Modena D; Preclinical R&D, Italfarmaco Group, 20092 Cinisello Balsamo, Milan, Italy., Moras ML; Preclinical R&D, Italfarmaco Group, 20092 Cinisello Balsamo, Milan, Italy., Sandrone G; Preclinical R&D, Italfarmaco Group, 20092 Cinisello Balsamo, Milan, Italy., Stevenazzi A; Preclinical R&D, Italfarmaco Group, 20092 Cinisello Balsamo, Milan, Italy., Vergani B; Preclinical R&D, Italfarmaco Group, 20092 Cinisello Balsamo, Milan, Italy., Dasgupta P; Institute of Pharmacology and Toxicology, Universitätsklinikum Jena, Friedrich-Schiller-Universität, 07747 Jena, Germany., Kliever A; Institute of Pharmacology and Toxicology, Universitätsklinikum Jena, Friedrich-Schiller-Universität, 07747 Jena, Germany., Gulde S; Institute for Diabetes and Cancer, Helmholtz Zentrum München, 85764 Neuherberg, Germany.; Joint Heidelberg-IDC Translational Diabetes Program, Heidelberg University Hospital, 69120 Heidelberg, Germany., Marangelo A; Institute for Diabetes and Cancer, Helmholtz Zentrum München, 85764 Neuherberg, Germany.; Joint Heidelberg-IDC Translational Diabetes Program, Heidelberg University Hospital, 69120 Heidelberg, Germany.; Department of Biology and Biotechnology 'L. Spallanzani', University of Pavia, 27100 Pavia, Italy., Schillmaier M; Department of Nuclear Medicine, Klinikum Rechts der Isar, School of Medicine, Technical University of Munich, 80333 Munich, Germany.; Department of Diagnostic and Interventional Radiology, Klinikum Rechts der Isar, School of Medicine, Technical University of Munich, 80333 Munich, Germany., Luque RM; Maimonides Biomedical Research Institute of Cordoba (IMIBIC), 14004 Cordoba, Spain.; Department of Cell Biology, Physiology and Immunology, University of Cordoba, 14004 Cordoba, Spain.; Reina Sofia University Hospital (HURS), 14004 Cordoba, Spain.; CIBER Physiopathology of Obesity and Nutrition (CIBERobn), 14004 Cordoba, Spain., Bäuerle S; Department of Mathematics, Technical University Munich, 85748 Garching, Germany., Pellegata NS; Institute for Diabetes and Cancer, Helmholtz Zentrum München, 85764 Neuherberg, Germany.; Joint Heidelberg-IDC Translational Diabetes Program, Heidelberg University Hospital, 69120 Heidelberg, Germany.; Department of Biology and Biotechnology 'L. Spallanzani', University of Pavia, 27100 Pavia, Italy., Schulz S; Institute of Pharmacology and Toxicology, Universitätsklinikum Jena, Friedrich-Schiller-Universität, 07747 Jena, Germany., Steinkühler C; Preclinical R&D, Italfarmaco Group, 20092 Cinisello Balsamo, Milan, Italy.
Source: Cancers [Cancers (Basel)] 2023 Jun 30; Vol. 15 (13). Date of Electronic Publication: 2023 Jun 30.
Publication Type: Journal Article
Journal Info: Publisher: MDPI Country of Publication: Switzerland NLM ID: 101526829 Publication Model: Electronic Cited Medium: Print ISSN: 2072-6694 (Print) Linking ISSN: 20726694 NLM ISO Abbreviation: Cancers (Basel) Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 37444563
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Identification of a Novel SSTR3 Full Agonist for the Treatment of Nonfunctioning Pituitary Adenomas.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Modena+D%22">Modena D</searchLink>; Preclinical R&D, Italfarmaco Group, 20092 Cinisello Balsamo, Milan, Italy.<br /><searchLink fieldCode="AU" term="%22Moras+ML%22">Moras ML</searchLink>; Preclinical R&D, Italfarmaco Group, 20092 Cinisello Balsamo, Milan, Italy.<br /><searchLink fieldCode="AU" term="%22Sandrone+G%22">Sandrone G</searchLink>; Preclinical R&D, Italfarmaco Group, 20092 Cinisello Balsamo, Milan, Italy.<br /><searchLink fieldCode="AU" term="%22Stevenazzi+A%22">Stevenazzi A</searchLink>; Preclinical R&D, Italfarmaco Group, 20092 Cinisello Balsamo, Milan, Italy.<br /><searchLink fieldCode="AU" term="%22Vergani+B%22">Vergani B</searchLink>; Preclinical R&D, Italfarmaco Group, 20092 Cinisello Balsamo, Milan, Italy.<br /><searchLink fieldCode="AU" term="%22Dasgupta+P%22">Dasgupta P</searchLink>; Institute of Pharmacology and Toxicology, Universitätsklinikum Jena, Friedrich-Schiller-Universität, 07747 Jena, Germany.<br /><searchLink fieldCode="AU" term="%22Kliever+A%22">Kliever A</searchLink>; Institute of Pharmacology and Toxicology, Universitätsklinikum Jena, Friedrich-Schiller-Universität, 07747 Jena, Germany.<br /><searchLink fieldCode="AU" term="%22Gulde+S%22">Gulde S</searchLink>; Institute for Diabetes and Cancer, Helmholtz Zentrum München, 85764 Neuherberg, Germany.; Joint Heidelberg-IDC Translational Diabetes Program, Heidelberg University Hospital, 69120 Heidelberg, Germany.<br /><searchLink fieldCode="AU" term="%22Marangelo+A%22">Marangelo A</searchLink>; Institute for Diabetes and Cancer, Helmholtz Zentrum München, 85764 Neuherberg, Germany.; Joint Heidelberg-IDC Translational Diabetes Program, Heidelberg University Hospital, 69120 Heidelberg, Germany.; Department of Biology and Biotechnology 'L. Spallanzani', University of Pavia, 27100 Pavia, Italy.<br /><searchLink fieldCode="AU" term="%22Schillmaier+M%22">Schillmaier M</searchLink>; Department of Nuclear Medicine, Klinikum Rechts der Isar, School of Medicine, Technical University of Munich, 80333 Munich, Germany.; Department of Diagnostic and Interventional Radiology, Klinikum Rechts der Isar, School of Medicine, Technical University of Munich, 80333 Munich, Germany.<br /><searchLink fieldCode="AU" term="%22Luque+RM%22">Luque RM</searchLink>; Maimonides Biomedical Research Institute of Cordoba (IMIBIC), 14004 Cordoba, Spain.; Department of Cell Biology, Physiology and Immunology, University of Cordoba, 14004 Cordoba, Spain.; Reina Sofia University Hospital (HURS), 14004 Cordoba, Spain.; CIBER Physiopathology of Obesity and Nutrition (CIBERobn), 14004 Cordoba, Spain.<br /><searchLink fieldCode="AU" term="%22Bäuerle+S%22">Bäuerle S</searchLink>; Department of Mathematics, Technical University Munich, 85748 Garching, Germany.<br /><searchLink fieldCode="AU" term="%22Pellegata+NS%22">Pellegata NS</searchLink>; Institute for Diabetes and Cancer, Helmholtz Zentrum München, 85764 Neuherberg, Germany.; Joint Heidelberg-IDC Translational Diabetes Program, Heidelberg University Hospital, 69120 Heidelberg, Germany.; Department of Biology and Biotechnology 'L. Spallanzani', University of Pavia, 27100 Pavia, Italy.<br /><searchLink fieldCode="AU" term="%22Schulz+S%22">Schulz S</searchLink>; Institute of Pharmacology and Toxicology, Universitätsklinikum Jena, Friedrich-Schiller-Universität, 07747 Jena, Germany.<br /><searchLink fieldCode="AU" term="%22Steinkühler+C%22">Steinkühler C</searchLink>; Preclinical R&D, Italfarmaco Group, 20092 Cinisello Balsamo, Milan, Italy.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101526829%22">Cancers</searchLink> [Cancers (Basel)] 2023 Jun 30; Vol. 15 (13). <i>Date of Electronic Publication: </i>2023 Jun 30.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22MDPI%22">MDPI </searchLink><i>Country of Publication: </i>Switzerland <i>NLM ID: </i>101526829 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Print <i>ISSN: </i>2072-6694 (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2220726694%22">20726694 </searchLink><i>NLM ISO Abbreviation: </i>Cancers (Basel) <i>Subsets: </i>PubMed not MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=37444563
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.3390/cancers15133453
    Languages:
      – Code: eng
        Text: English
    Titles:
      – TitleFull: Identification of a Novel SSTR3 Full Agonist for the Treatment of Nonfunctioning Pituitary Adenomas.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Modena D
      – PersonEntity:
          Name:
            NameFull: Moras ML
      – PersonEntity:
          Name:
            NameFull: Sandrone G
      – PersonEntity:
          Name:
            NameFull: Stevenazzi A
      – PersonEntity:
          Name:
            NameFull: Vergani B
      – PersonEntity:
          Name:
            NameFull: Dasgupta P
      – PersonEntity:
          Name:
            NameFull: Kliever A
      – PersonEntity:
          Name:
            NameFull: Gulde S
      – PersonEntity:
          Name:
            NameFull: Marangelo A
      – PersonEntity:
          Name:
            NameFull: Schillmaier M
      – PersonEntity:
          Name:
            NameFull: Luque RM
      – PersonEntity:
          Name:
            NameFull: Bäuerle S
      – PersonEntity:
          Name:
            NameFull: Pellegata NS
      – PersonEntity:
          Name:
            NameFull: Schulz S
      – PersonEntity:
          Name:
            NameFull: Steinkühler C
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 30
              M: 06
              Text: 2023 Jun 30
              Type: published
              Y: 2023
          Identifiers:
            – Type: issn-print
              Value: 2072-6694
          Numbering:
            – Type: volume
              Value: 15
            – Type: issue
              Value: 13
          Titles:
            – TitleFull: Cancers
              Type: main
ResultId 1